Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
PUT
iShares MSCI Mexico ETF
EWW
$1.79B
| $87.5M | 0.04% |
1,803,900
+1,326,100
| +278% | +$66.6M |
|
|
CHK
352
PUT
DELISTED
Chesapeake Energy Corporation
CHK
| $87.1M | 0.04% |
69,486
-8,662
| -11% | -$9.99M |
|
353
PUT
Devon Energy
DVN
$52.6B
| $86.8M | 0.04% |
1,968,500
-331,800
| -14% | -$13.5M |
|
354
CALL
CVS Health
CVS
$119B
| $86.8M | 0.04% |
975,000
-245,200
| -20% | -$23.1M |
|
355
PUT
Colgate-Palmolive
CL
$73.3B
| $86.6M | 0.04% |
1,167,900
+995,400
| +577% | +$73.6M |
|
356
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$361M
| $86.4M | 0.04% |
790,300
-2,707,400
| -77% | -$294M |
|
|
EA
357
PUT
DELISTED
Electronic Arts
EA
| $85.9M | 0.04% |
1,005,900
-331,700
| -25% | -$26.5M |
|
358
CALL
Viatris
VTRS
$18.8B
| $85.2M | 0.04% |
2,234,800
+411,500
| +23% | +$18.3M |
|
359
CALL
American Tower
AMT
$82.7B
| $84.6M | 0.04% |
746,200
+146,600
| +24% | +$16.8M |
|
360
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.5B
| $84M | 0.04% |
1,267,200
-289,900
| -19% | -$17.9M |
|
|
VIAB
361
PUT
DELISTED
Viacom Inc. Class B
VIAB
| $83.7M | 0.04% |
2,196,500
+1,170,000
| +114% | +$48.5M |
|
|
362
CALL
Colgate-Palmolive
CL
$73.3B
| $83.5M | 0.04% |
1,125,600
-353,100
| -24% | -$26.1M |
|
363
CALL
Phillips 66
PSX
$96.1B
| $83.3M | 0.04% |
1,034,100
-120,600
| -10% | -$9.37M |
|
364
PUT
Las Vegas Sands
LVS
$30.4B
| $83.1M | 0.04% |
1,444,000
-478,000
| -25% | -$24.6M |
|
365
PUT
RTX Corp
RTX
$282B
| $82.9M | 0.04% |
1,296,147
-594,286
| -31% | -$39.4M |
|
|
WBA
366
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $82.7M | 0.04% |
1,026,400
-1,053,800
| -51% | -$85.9M |
|
367
CALL
BP
BP
$112B
| $82.7M | 0.04% |
2,794,275
-966,842
| -26% | -$28.1M |
|
368
PUT
Constellation Brands
STZ
$23.6B
| $82.6M | 0.04% |
496,300
-92,400
| -16% | -$15.2M |
|
369
PUT
Freeport-McMoran
FCX
$110B
| $82.5M | 0.04% |
7,595,500
-771,300
| -9% | -$8.87M |
|
370
CALL
Conagra Brands
CAG
$7.99B
| $82.3M | 0.04% |
2,243,610
+1,341,668
| +149% | +$48.1M |
|
371
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$300M
| $81.4M | 0.04% |
2,577,300
-241,500
| -9% | -$7.56M |
|
|
VIAB
372
CALL
DELISTED
Viacom Inc. Class B
VIAB
| $81.2M | 0.04% |
2,130,200
+37,600
| +2% | +$1.56M |
|
373
WisdomTree Japan Hedged Equity Fund
DXJ
$7.23B
| $80.8M | 0.04% |
1,883,158
+1,560,305
| +483% | +$64.8M |
|
374
CALL
Enterprise Products Partners
EPD
$82.1B
| $80.6M | 0.04% |
2,917,800
+344,400
| +13% | +$9.52M |
|
|
YHOO
375
DELISTED
Yahoo Inc
YHOO
| $80.6M | 0.04% |
1,869,141
-1,083,290
| -37% | -$44.4M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.